evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract
19193,GENE_BACKGROUND,,"The LYN gene encodes a non-receptor tyrosine kinase of the Src family (PMID: 9202419). LYN is involved in immune responses, B-cell signaling, signal transduction of growth factors and response to DNA damage, among other functions (PMID: 19290919, 10574931, 11825908, 11435302). LYN is a mediator that can positively or negatively regulate different processes depending on the cellular and physiological context (PMID: 15664155). LYN has been described to promote tumor growth, invasion, epithelial to mesenchymal transition (EMT) and ERK signaling in different cancer contexts (PMID: 20215510, 22490227, 22731636). The LYN gene is typically altered by amplification in various tumors, including prostate, breast and ovarian cancers (cBioPortal, MSKCC, Nov 2016). LYN can be pharmacologically targeted with Src-kinase inhibitors, such as dasatinib (PMID: 20215510, 22490227, 18056483).",,2017-03-28,,4067,LYN,"LYN proto-oncogene, Src family tyrosine kinase",False,ENST00000519728,NM_002350.3,p53Lyn,p56Lyn,JTK8,False,20215510,LYN is a mediator of epithelial-mesenchymal transition and a target of dasatinib in breast cancer.,Cancer research,2018-03-15T20:10:00,70,6,2296-306,Choi YL et al,doi: 10.1158/0008-5472.CAN-09-3141,,2018-03-15T03:06:00,,9202419,"Lyn, a src-like tyrosine kinase.",The international journal of biochemistry &amp; cell biology,0001-03-01,29,3,397-400,Hibbs ML et al,,,2018-03-01T04:00:00,,11825908,Phosphatidylinositol 3-kinase and Src family kinases are required for phosphorylation and membrane recruitment of Dok-1 in c-Kit signaling.,The Journal of biological chemistry,2018-04-19T20:02:00,277,16,13732-8,Liang X et al,,,0001-04-19,,22490227,Lyn kinase mediates cell motility and tumor growth in EGFRvIII-expressing head and neck cancer.,Clinical cancer research : an official journal of the American Association for Cancer Research,2018-05-15T20:12:00,18,10,2850-60,Wheeler SE et al,doi: 10.1158/1078-0432.CCR-11-2486,,0001-05-15,,18056483,A critical role for Lyn in acute myeloid leukemia.,Blood,2018-02-15T20:08:00,111,4,2269-79,Dos Santos C et al,,,0001-02-15,,11435302,Lyn is required for normal stem cell factor-induced proliferation and chemotaxis of primary hematopoietic cells.,Blood,2018-07-15T20:01:00,98,2,343-50,O'Laughlin-Bunner B et al,,,0001-07-15,,22731636,Lyn is involved in CD24-induced ERK1/2 activation in colorectal cancer.,Molecular cancer,2018-06-26T20:12:00,11,,43,Su N et al,doi: 10.1186/1476-4598-11-43,,0001-06-26,,19290919,Multiple roles of Lyn kinase in myeloid cell signaling and function.,Immunological reviews,2018-03-01T20:09:00,228,True,23-40,Scapini P et al,doi: 10.1111/j.1600-065X.2008.00758.x,,0001-03-01,,10574931,Functional interaction between SHPTP1 and the Lyn tyrosine kinase in the apoptotic response to DNA damage.,The Journal of biological chemistry,0001-12-03,274,49,34663-8,Yoshida K et al,,,0001-12-03,,15664155,Lyn tyrosine kinase: accentuating the positive and the negative.,Immunity,2018-01-01T20:05:00,22,True,2001-09-18,Xu Y et al,,,0001-01-01,
19192,GENE_SUMMARY,,"LYN, a non-receptor tyrosine kinase, is altered by amplification in various cancers.",,2017-03-28,,4067,LYN,"LYN proto-oncogene, Src family tyrosine kinase",False,ENST00000519728,NM_002350.3,p53Lyn,p56Lyn,JTK8,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
